Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37151 - 37175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	FAM71E1	112703	upregulated	entinostat results in increased expression of FAM71E1 mRNA	19q13.33	A21037 A21035
Entinostat	Investigational	FAM78A	286336	upregulated	entinostat results in increased expression of FAM78A mRNA	9q34.13	A21037
Entinostat	Investigational	FAM84A	151354	downregulated	entinostat results in decreased expression of FAM84A mRNA	2p24.3	A21037
Entinostat	Investigational	FANK1	92565	downregulated	entinostat results in decreased expression of FANK1 mRNA	10q26.2	A21037
Entinostat	Investigational	FAR2	55711	downregulated	entinostat results in decreased expression of FAR2 mRNA	12p11.22	A21037
Entinostat	Investigational	FARP1	10160	downregulated	entinostat results in decreased expression of FARP1 mRNA	13q32.2	A21037
Entinostat	Investigational	FARP2	9855	upregulated	entinostat results in increased expression of FARP2 mRNA	2q37.3	A21035
Entinostat	Investigational	FAS	355	upregulated	entinostat results in increased expression of FAS mRNA	10q23.31	A21035
Entinostat	Investigational	FAT3	120114	downregulated	entinostat results in decreased expression of FAT3 mRNA	11q14.3	A21037
Entinostat	Investigational	FAXC	84553	downregulated	entinostat results in decreased expression of FAXC mRNA	6q16.2	A21035
Entinostat	Investigational	FBLIM1	54751	upregulated	entinostat results in increased expression of FBLIM1 mRNA	1p36.21	A21037 A21035
Entinostat	Investigational	FBLL1	345630	downregulated	entinostat results in decreased expression of FBLL1 mRNA	5q34	A21035
Entinostat	Investigational	FBLL1	345630	upregulated	entinostat results in increased expression of FBLL1 mRNA	5q34	A21037
Entinostat	Investigational	FBLN2	2199	upregulated	entinostat results in increased expression of FBLN2 mRNA	3p25.1	A21037
Entinostat	Investigational	FBLN5	10516	upregulated	entinostat results in increased expression of FBLN5 mRNA	14q32.12	A21035
Entinostat	Investigational	FBLN7	129804	downregulated	entinostat results in decreased expression of FBLN7 mRNA	2q13	A21037
Entinostat	Investigational	FBN1	2200	downregulated	entinostat results in decreased expression of FBN1 mRNA	15q21.1	A21037
Entinostat	Investigational	FBN2	2201	downregulated	entinostat results in decreased expression of FBN2 mRNA	5q23.3	A21037
Entinostat	Investigational	FBXL13	222235	upregulated	entinostat results in increased expression of FBXL13 mRNA	7q22.1	A21037
Entinostat	Investigational	FBXL14	144699	downregulated	entinostat results in decreased expression of FBXL14 mRNA	12p13.33	A21037
Entinostat	Investigational	FBXL16	146330	upregulated	entinostat results in increased expression of FBXL16 mRNA	16p13.3	A21037
Entinostat	Investigational	FBXL17	64839	downregulated	entinostat results in decreased expression of FBXL17 mRNA	5q21.3	A21037
Entinostat	Investigational	FBXL21	26223	upregulated	entinostat results in increased expression of FBXL21 mRNA	5q31.1	A21037 A21035
Entinostat	Investigational	FBXL3	26224	downregulated	entinostat results in decreased expression of FBXL3 mRNA	13q22.3	A21035
Entinostat	Investigational	FBXO16	157574	upregulated	entinostat results in increased expression of FBXO16 mRNA	8p21.1	A21035

Displaying entries 37151 - 37175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability